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A key step towards a chemical picture of enzyme catalysis
was taken in 1913, when Leonor Michaelis and Maud
Menten published their studies of sucrose hydrolysis by
invertase. Based on a novel experimental design and a
mathematical model, their work offered a quantitative
view of biochemical kinetics well before the protein nature
of enzymes was established and complexes with sub-
strates could be detected. Michaelis–Menten kinetics pro-
vides a solid framework for enzyme kinetics in vitro, but
what about kinetics in cells, where enzymes can be highly
regulated and participate in a multitude of interactions?
We discuss this question using the Extracellular Signal
RegulatedKinase (ERK), which controls amyriad functions
in cells, as a model of an important enzyme for which we
have crystal structures, quantitative in vitro assays, and
a vast list of binding partners. Despite great progress, we
still cannot quantitatively predict how the rates of ERK–
dependent reactions respond to genetic and pharma-
cological perturbations. Achieving this goal, which is
important from both fundamental and practical stand-
points, requires measuring the rates of enzyme reactions
in their native environment and interpreting these
measurements using simple but realistic mathematical
models — the two elements which served as the corner-
stones for Michaelis’ and Menten’s seminal 1913 paper.
Introduction
One hundred years ago, Leonor Michaelis and MaudMenten
published their landmark paper on enzyme kinetics, in which
they studied how a two–ring sugar, sucrose, is hydrolyzed by
a yeast–derived enzyme, invertase, so named because hy-
drolysis changes optical rotation from positive for sucrose
to negative for the mixture of fructose and glucose
(Figure 1A) [1–3]. The choice of this chemical reaction can
be traced back to Louis Pasteur, a founding father of micro-
biology who made many remarkable discoveries, but was
convinced that enzyme reactions require the presence of
living organisms that provide a vital force, irreducible to
laws of physics and chemistry. By 1913, this view had been
losing ground, largely due to the work of Eduard Buchner,
who demonstrated fermentation in the absence of living
cells. This reinforced the view that enzymes can be under-
stood using the principles of chemistry, at that time, still an
emerging discipline, with Emil Fischer as one of the leading
figures, famous for his synthesis of natural products,
including sugars [4].
Working with synthetic sugars and different types of yeast
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and their substrates and put forward his famous ‘lock–and–
key’ model of enzyme action. Michaelis’ and Menten’s
approach to evaluating Fischer’smodel was based on formal
chemical kinetics, which is standard today but had been only
a couple of decades old in the beginning of the 20th century.
In this approach, one postulates a mechanism and derives
from it an algebraic equation for the overall reaction rate as
a function of reaction conditions, such as reactant concen-
trations. Fitting the derived equation to rates measured
over a range of conditions can be used to assess the validity
of the mechanism [5].
The first application of kinetic approach to enzymes is
attributed to Victor Henri, whose dissertation, published in
1903, contains the now familiar mechanism in which revers-
ible formation of a complex precedes its irreversible decom-
position into enzyme and product (Figure 1B) [4,5]. However,
analysis of Henri’s data was complicated by product inhibi-
tion, which was significant at high substrate conversions in
his experiments. Michaelis and Menten worked at low sub-
strate conversions and measured initial rates of reaction,
which allowed them to neglect product inhibition and simpli-
fied kinetic analysis. Their analysis revealed that the rate of
reaction is accurately described by a simple formula, linear
at small substrate concentrations and approaching a con-
stant value when substrate concentrations are high
(Figure 1C,D) [6]. The fact that one formula fit the data over
a wide range of substrate concentrations was clearly consis-
tent with Fischer’s idea and Henri’s mechanism. A rigorous
proof of this mechanism, based on direct observation of
enzyme–substrate complexes, appeared only decades later,
after the protein nature of enzymes was established [7,8].
Nevertheless, the clarity of the paper made it an instant
classic and ensured that kinetic approach was rapidly
applied to other enzymes.
The groundbreaking studies on invertase took the first
steps towards establishing a chemical picture of a constitu-
tively active enzyme that processes a single substrate. But
things are much more complex inside cells, where enzymes
can be highly regulated and need to work on multiple sub-
strates. Our understanding of such systems is still incom-
plete, despite great advances in conceptual analysis of
intracellular processes and their experimental analysis.
Here, we use the Extracellular Signal–Regulated Kinase1/2
(henceforth, ERK) as a model to highlight some of the most
important aspects of enzyme kinetics in cells. Some of
them, such as substrate selectivity, can be addressed by
studies with a small number of purified components. Other
features, such as spatial control of enzyme activity, require
studies in vivo. The general concepts developed by Michae-
lis and Menten still hold, but they must be applied in the
context of enzyme networks and complex intracellular
environments.
A Brief History of ERK
ERK was discovered in studies of protein phosphorylation,
in the context of cell stimulation by growth factors, which
act through receptor tyrosine kinases [9,10]. The first pro-
tein shown to undergo phosphorylation in response to
growth factors was the ribosomal protein S6. As this pro-
tein is phosphorylated on serine residues, it cannot be a
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Figure 1. The Michaelis–Menten model of enzyme kinetics.
(A) Yeast invertase and the hydrolysis of sucrose to glucose (top) and
fructose (bottom). Structure of Saccharomyces cerevisiae invertase
drawn from PDB file 4EQV [1]. (B) The model proposed by Michaelis
and Menten, wherein an enzyme and a substrate bind reversibly to
form a complex, which is converted to a product and the enzyme. (C)
The Michaelis–Menten equation and its graphical representation. Plot-
ting the initial rate against the substrate concentration enables the
determination of both Vmax andKm. (D) Lineweaver Burk representation
of the Michaelis–Menten equation. Taking the reciprocal of both sides
of the Michaelis–Menten equation yields a linear relationship. Plotting
the reciprocal of the initial rate vs. the reciprocal of substrate concen-
tration allows the determination of Km and Vmax from the y and x inter-
cept and the slope of the line.
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Figure 2. Patterns of ERK activation in organisms.
(A) ERK activation requires its phosphorylation by MEK. Active ERK
controls cellular processes by phosphorylating multiple substrates.
(B) Active ERK (red) at three different time points in Drosophila em-
bryos. Active ERK is first detected at the embryonic poles, where it
specifies the nonsegmented terminal regions of the future larva. Within
the next 30minutes, ERK is activated in a lateral domain corresponding
to the presumptive neurogenic ectoderm. After gastrulation, ERK is
active along the ventral midline and in tracheal pits.
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R973direct substrate of tyrosine kinases. This led to the identi-
fication of the protein Ser/Thr kinases RSK and S6K,
which are themselves activated by phosphorylation on
serines and threonines. The kinase responsible for the
phosphorylation of RSK was discovered by Sturgill and
Ray [11], and the corresponding gene was subsequently
cloned by Cobb and collaborators [12,13]. Although it
was initially known by several distinct acronyms, the en-
zyme’s name settled on the Extracellular Signal–Regulated
Kinase (ERK).
ERK became the founding member of Mitogen Activated
Protein Kinases (MAPKs), a class of serine/threonine kinases
which control a wide range of processes in adult and devel-
oping cells [14]. Enzymatic activity of ERK requires its phos-
phorylation on Tyr and Thr within the activation loop of the
kinase [15]. The dual–specificity protein kinase responsible
for this activation was identified [16,17] and cloned [18,19]
shortly after the cloning of ERK itself, and was termed MAP
Kinase/ERK Kinase (MEK). The reverse modification, which
dephosphorylates and deactivates ERK, is accomplishedby phosphatases, which were identified relatively early in
ERK research [20,21].
In the beginning of the 1990s, studies in model genetic
organisms, most notably Drosophila melanogaster, began
to complement experiments in cultured cells and established
that ERK plays a key role in embryogenesis [22]. In vivo
effects of ERK were initially studied by observing con-
sequences of ERK mutations on morphological structures,
such as the faceted Drosophila eye [23]. An antibody that
recognizes the active, dually phosphorylated form of
the enzyme (dpERK) (Figure 2) revealed intricate spatiotem-
poral patterns of ERK activation in vivo [24,25]. The emer-
gence of these patterns and analysis of their effects on
processes such as gene expression and morphogenesis is
a subject of intensive research in different model systems,
from gonad development in worms to segmentation in
vertebrates [26,27].
Over time, multiple substrates of ERK have been identified
and their sensitivity to ERK dissected at the molecular level
[28–30]. These studies revealed the importance of docking
interactions, which use distinct parts of the ERK molecule,
bringing it together with a wide range of binding partners
[31,32]. The first structures of ERK, active or inactive
[33,34], and in complexes with some of its regulators and
substrates appeared over the past two decades, providing
important insights into the mechanisms of ERK activation
and specificity.
The first proof of association between deregulated ERK
activation and human disease appeared in 1994 [35]. Subse-
quent work established that deregulation can result from
gain of function mutations in the signaling cascade that links
RTKs to ERK. In particular, gain of function mutations in en-
zymes that activate ERK were identified in a broad spectrum
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Figure 3. ERK2 docking domains and ERK2
substrate docking sites.
(A) ERK2 structure with docking domains —
DRS domain (left) and FRS domain (right) —
and active site (middle) in space filling repre-
sentation. Structure drawn from PDB file
1ERK [33]. (B) Schematic representation of
ERK2 substrate sequence containing a dock-
ing site and a (S/T)P phosphorylation site. (C)
Alignment of F-site and D-site sequences
from multiple ERK2 interacting substrates
and regulators. (D) Schematic representation
of ERK2 interactions with substrate docking
site and (S/T)P phosphorylation motif. (E) Ef-
fects of mutations on substrate docking site
and phosphorylation site and insights into
molecular mechanisms of ERK2 catalysis. (i)
Wild-type substrate and associated Michae-
lis–Menten parameters. (ii) Substrate with
docking site mutations and associated
Michaelis–Menten parameters. Mutating the
docking site significantly increases the Km
but has little effect on kcat. (iii) Substrate with
phosphorylation motif mutations and associ-
ated Michaelis–Menten parameters. Mutating
the phosphorylation motif significantly de-
creases the kcat but has little effect on Km.
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R974of human cancers and developmental abnormalities [36]. The
emerging picture of ERK regulation and function is complex,
involving numerous components and layers of regulation
[14,37]. Mathematical modeling, which was an integral part
of the Michaelis and Menten paper, provides a sensible
way of dealing with this complexity [38–41]. Mathematical
models have been used to integrate data from a wide range
of experimental approaches and predict howERK activity re-
sponds to genetic and pharmacological perturbations. All of
these models use the Michaelis–Menten description of
enzyme kinetics as a building block of more complex net-
works. As this description was established based on studies
with isolated components, it is reasonable to askwhether it is
appropriate for enzymes in cells. Belowwewill try to address
this question for ERK, keeping in mind that studies of one
enzyme can have broad implications for biological regulation
in general. Indeed, this turned out to be true for invertase.
Quantitative Analysis of ERK–Substrate Interactions
Michaelis and Menten studied an enzyme that is highly
specific: invertase only acts on sucrose. Such specificity
is fairly common for enzymes with small molecule sub-
strates that bury themselves in clefts where catalysis oc-
curs. Thus, the formation of the enzyme–substrate
complex is closely coupled to catalysis. However, other en-
zymes — especially those that act on proteins — behave
differently and have multiple substrates. ERK is a vivid
example of an enzyme with broad specificity and is believed
to have over 250 substrates [42–44]. Protein substrates are
modified at specific positions that interact with the active
site. However, the large size of these substrates enablesbinding between the substrate and
enzyme at positions that are distal to
the site of catalysis. These docking
site interactions play an important
role in targeting the activity of en-
zymes to their substrates.While ERK phosphorylation is targeted to specific sites —
a serine or a threonine followed by a proline ((S/T)P) — these
sites are quite common, occurring in approximately 80% of
all proteins [45]. Clearly, catalytic site targeting is insufficient
to guide ERK to substrates. Instead, specific docking
domains on ERK and its substrates are used to enhance
targeting. There are two well-characterized docking do-
mains on ERK termed the D Recruitment Site (DRS; also
called CD domain), which interacts with D site motifs (also
called DEJL motifs) on ERK-interacting proteins, and the F
Recruitment Site (FRS), which interacts with proteins con-
taining an F site (also called FXF motif, DEF motif) [32,46–
49] (Figure 3A–C).
Docking sites do not only increase the specificity of the
ERK–substrate interaction, they often increase efficiency of
ERK-mediated phosphorylation [49]. This may seem coun-
terintuitive; tight docking interactions could theoretically
reduce substrate turnover if ERK substrates are not released
promptly after phosphorylation. It appears that many ERK–
substrate interactions are destabilized after phosphorylation
[50] and others may be sufficiently weak, allowing ERK to
dissociate from a phosphorylated product after catalysis
has occurred.
Because the formation of the enzyme–substrate complex
employs interactions distal to the active site, the formation
of the complex can be functionally separated from catalysis.
This can be clearly seen in theMichaelis–Menten parameters
extracted from studies of ERK-dependent phosphorylation
in vitro. For example, Ets1, a transcription factor phosphory-
lated by ERK, contains both an ERK binding site and a distal
phosphorylation site (TP). Phosphorylation of this substrate
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Figure 4. Identification of ERK substrates in C. elegans.
(A) Dissected C. elegans hermaphrodite germ line from wild-type ani-
mals oriented from left to right, stained for dpERK (red) and DNA
(white). Wild-type germ lines reveal two zones of ERK activation,
zone 1 and 2, with brief downregulation of active ERK in the loop re-
gion. (B) Schematic representation of ERK substrates identified in
C. elegans by searching the genome for ERK docking site motifs and
screening putative substrates in vivo [26].
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R975was studied by separating and quantifying the role of the
binding site and phosphorylation motif [51]. Interestingly,
mutations to each of these sites have a distinct effect on
ERK-mediated phosphorylation. Mutating the proline in the
TP site to different amino acids has a significant effect on
the rate of phosphorylation, kcat, despite the relatively
weak effect these mutations have on equilibrium dissocia-
tion constants. On the other hand, mutations in the docking
site do not have a significant effect on kcat, but lead to much
weaker binding to ERK and thus increase the dissociation
constant and Km (Figure 3D,E).
Overall, mutations to both the phosphorylation motif and
the docking site affect the ability of Ets1 and ERK to form a
catalytically relevant complex, but in very different ways.
The binding site increases the local concentration of the TP
motif near the catalytic site, but has little effect on catalysis.
On the other hand, the TP sequence is critical for positioning
residues for the transfer of a phosphoryl group to Ets1, but
does not have a significant effect on the strength of the
ERK–Ets1 binding (Figure 3D,E). Thus, studies of enzyme
catalysis using modern techniques such as directed muta-
genesis and kinase activity and binding assays revealed
mechanisms that could never have been imagined in 1913.
Yet, we are still able to interpret and model these mecha-
nisms using the language of the 1913 paper.
Identification of ERK Substrates
Elucidating the parameters that describe ERK activity in a
test tube provides valuable information, but it says nothing
about which substrates it is acting on in a cell or an organism.
This question goes beyond the scope of studies enabled by
the Michaelis–Menten model, which focuses on one enzyme
and one substrate. However, knowing what makes a protein
an ERK substrate—such as sequences of binding andphos-
phorylation sites — and the advent of post-genomic tech-
niques have enabled us to begin to piece together the
puzzle [26,43,52–58].
The proteomic approach aims to find proteins whose inter-
actions with ERK or phosphorylation state change upon ERK
activation. A number of studies have used two-dimensional
gel electrophoresis to separate proteins by mass and iso-
electric point in cells with and without initiation of ERK activ-
ity. Proteins that have been phosphorylated will shift
positions on a gel, and characterization by mass spectrom-
etry enables the identification of the proteins that display
this behavior [53,54]. These studies provide lists of ERK
pathway targets and can identify its novel physiological
functions. For example, Kosako et al. [43] used this approach
to identify a component of the nuclear pore as a new ERK
substrate and proposed that ERK regulates nucleocytoplas-
mic transport. Clearly, intracellular proteins phosphorylated
in response to ERK activation are not necessarily ERK sub-
strates. Instead, their phosphorylation may be induced by
enzymes controlled by the ERK pathway. A different set of
techniques aims to identify direct binding partners of ERK
[52,55–58]. In particular, von Kriegsheim and colleagues
[56] assessed the relative amounts of proteins that co-immu-
noprecipitate with ERK from cells which had been exposed
to ERK activation for different periods of time. This study re-
vealed the highly dynamic nature of the ERK interactome and
its sensitivity to the level of pathway activation.
Knowledge about the molecular-level mechanisms of
enzyme–substrate interactions and genome sequencing
made it possible to combine bioinformatics with geneticsand biochemistry to identify ERK substrates in vivo. In a
recent study of ERK effects in Caenorhabditis elegans germ-
line development (Figure 4A), consensus sequences of bind-
ing and phosphorylation sites were used to computationally
search for ERK substrates in the C. elegans genome [26]. A
list of substrate candidates was generated by searching the
proteome for ERK docking sites in the vicinity of phosphory-
lation motifs. Candidate substrates were then screened
in vivo, using RNAi knockdown to identify which are respon-
sible for translating ERK signaling into multiple aspects of
germ-line development. In this way, a list of 161 candidates
predicted by bioinformatics led to 37 proteins that regulate
ERK-dependent biological processes in vivo. Finally, in vitro
phosphorylation assays confirmed that many of these pro-
teins are true ERK substrates (Figure 4B). Thus, in this com-
bined bioinformatic, genetic and biochemical approach ERK
substrateswerenotonly identified, but tied tospecificcellular
and developmental processes, such as translational control.
These studies reveal that analysis of the biological effects
of ERK activity requires simultaneous consideration of multi-
ple substrates. To model the enzymatic activity of ERK in
cells, even under highly simplified assumptions, we need
in vivo concentrations of ERK and its interactors, as well as
rates of association, dissociation and catalysis. Currently,
we have very little of this information for most ERK
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Figure 5. Substrate competition in the ERK
pathway.
(A) Substrate competition and its effects on
enzyme kinetics. When multiple substrates
compete for the activity of a single enzyme,
the rate of conversion of a single substrate
decreases as the concentration of competing
substrates increases. (B) ERK substrate
competition in the Drosophila embryo. Three
substrates — Bicoid (Bcd), Capicua (Cic)
and Hunchback (Hb) — compete for ERK
activity. (C) ERK-mediated downregulation of
Cic. At the embryonic poles, where ERK is
active, Cic is exported out of the nucleus
into the cytoplasm, where it is degraded. (D)
Distribution of ERK and its substrates in the
Drosophila embryo in the presence and
absence of substrate competition. ERK is
doubly phosphorylated and activated at the
poles of the embryo. Two substrates — Bcd
and Hb — are present only at the anterior
pole of the embryo. In wild-type embryos,
Cic is downregulated at the poles unevenly,
with a higher concentration at the anterior
pole. However, when the anteriorly located
ERK substrates Bcd and Hb are removed,
Cic is downregulated more evenly, indicating
that ERK’s ability to phosphorylate and down-
regulate Cic is inhibited by the presence of
these other ERK substrates at the anterior
pole.
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R976substrates. Furthermore, the identification of multiple sub-
strates and processes regulated by ERK raises a number
of questions that did not apply to the single substrate system
studied by Michaelis and Menten. One of these questions is
related to ERK substrate competition.
ERK Substrate Competition
How does ERKmultiplex between itsmultiple substrates at a
given time point (Figure 5A,B)?One can imagine two different
scenarios: in the first scenario, active ERK is present in
excess of its substrates. In this case, the enzyme is mostly
free, and its substrates can be viewed as independent sen-
sors of ERK activity which do not affect each other. Genetic
removal or overexpression of any given substrate will not
affect the extent towhich ERKmodifies other substrates pre-
sent in the cell. In this regime, the enzyme can be readily re-
cruited to modify new substrates. In a second scenario,
active ERK is saturated by substrates. What happens when
the expression levels of different substrates are perturbed
in this regime? A simplemathematicalmodel, where different
substrates of ERK act as competitive inhibitors of each
other, shows that the effect depends on substrate con-
centrations and their relative affinities for the enzyme
(Figure 5A,B). When ERK deals with a large number of sub-
strates, each of which amounts to a small fraction of its inter-
action partners, substrates are independent of each other,
just as in the case when ERK is present in excess. On the
other hand, when a substrate constitutes a significant frac-
tion of ERK interaction partners, its knockdown or over-
expression can strongly influence the effects of ERK on
other substrates.
Which of the two scenarios reflects the situation in cells?
At this point, as we are only beginning to identify ERK sub-
strates in different cell types and have no reliable estimates
of their concentrations and relative affinities for ERK, the
answer to this question is still unknown. Some insights canbe provided by studies in model organisms, such as
Drosophila, where multiple ERK substrates have been iden-
tified and several methods exist for perturbing their expres-
sion in vivo. A recent study of ERK signaling in the early
Drosophila embryo suggests that competition between
ERK substrates is appreciable in magnitude and functionally
significant [59]. In the early embryo, ERK is activated in a
localized pattern, with pronounced peaks at the anterior
and posterior poles (Figure 2B). One of the ERK substrates
in this system is a transcriptional repressor Capicua (Cic),
which is excluded from nuclei and degraded in the cyto-
plasm in response to phosphorylation by ERK (Figure 5C)
[60]. The spatial pattern of Cic downregulation is highly
asymmetric: Cic is downregulated much more strongly at
the posterior pole. Genetic experiments established that
this asymmetry reflects ERK substrate competition. Specif-
ically, at least two ERK substrates, the transcription factors
Bicoid and Hunchback, are localized to the anterior pole
where they act as competitive inhibitors of ERK-dependent
downregulation of Cic. Accordingly, genetic removal of these
substrates from the embryo increases the level of Cic down-
regulation at the anterior pole and makes the pattern of Cic
downregulation symmetric (Figure 5D) [59].
These observations are consistent with a simple Mass Ac-
tionmodel, where ERK substrates inhibit each other compet-
itively (Figure 5A,B). These competitive interactions can
spread through a larger network that controls gene regula-
tion in the embryo and subdivides it into different tissue
types [61]. Thus, at least in this particular system, it appears
that competition between ERK substrates is appreciable and
plays a role in determining the biological effects of ERK acti-
vation. These observations motivate multiple lines of inquiry:
first, it remains to be determined whether the observed
competition between ERK substrates implies that they use
the same docking site; second, it is important to determine
whether substrate competition is appreciable in other
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Figure 6. Regulation of ERK activity.
(A) Superimposition of inactive (black and red) and active (grey and
cyan) ERK2 highlighting the activation loop and phosphorylated resi-
dues. Structures of inactive and active ERK2 drawn from PDB files
1ERK and 2ERK, respectively [33,34]. [B] Schematic representation
of structural changes upon ERK activation and the effects on ATP/sub-
strate binding and orientation. Upon activation, the amino-terminal and
carboxy-terminal lobes of ERK rotate toward one another and residues
in the active site are repositioned, allowing proper binding and orienta-
tion of substrates for catalysis. (C) A classical single enzyme/substrate
network, exemplified by the system used by Michaelis and Menten
(invertase-mediated hydrolysis of sucrose). (D) A simplified ERK net-
work involving multiple individual enzyme–substrate interactions —
ERK activation by MEK, ERK inactivation by a phosphatase, and
ERK–mediated phosphorylation of one substrate.
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R977biological contexts. If this turns out to be the case, we might
need to rethink the interpretation of experiments based on
genetic perturbations of individual substrates.
Enzyme Regulation and Enzyme Networks
In cells, ERK cycles between a catalytically active and inac-
tive state. How can an enzyme’s activity be turned on and
off? The answer to this question can be explained by study-
ing the three-dimensional enzyme structure in atomic detail,
a line of inquiry that could not have been imagined in 1913.
ERK is a substrate of activating and deactivating enzymes.
The mechanism of this regulation is the addition of a
phosphoryl group by MEK to two positions on the ERK
activation loop, which causes a conformational rearrange-
ment [34,62,63]. The phosphorylation lip moves consider-
ably and the two lobes of the protein rotate closer to one
another. This forms a pocket allowing the proper binding
and orientation of substrate residues such that ERK can
transfer a phosphoryl group from ATP to the target residue.
This conformational change is reversed when ERK is de-
phosphorylated by one of a number of phosphatases
(Figure 6A,B) [64]. Note that the protein–protein interactions
responsible for ERK regulation share similarities with those
involved in ERK-mediated catalysis. MEK and phosphatases
often use the same docking sites to modify ERK’s activity
that ERK uses to phosphorylate its substrates [49]. Thus,
docking domains can be thought of as nodes for the multiple
reactions that ERK is involved in.
In order to predict the enzymatic activity of ERK in cells, we
must consider its phosphorylation and activation by MEK,
ERK-mediated phosphorylation of its many substrates and
deactivation by regulatory phosphatases (Figure 6C,D).
Each of these individual interactions can be modeled by
the Michaelis–Menten mechanism, but to fully capture the
behavior of ERK, these modules must be coupled in a model
that describes a complex network. Molecular level perturba-
tions can ripple through such networks and lead to systems
level responses that could not be predicted by looking at in-
dividual reactions [65,66].
One example of the surprising effects of network-level
interactions arose from the search for mutants of ERK
with increased activity. The sevenmaker gain of function
mutant of ERK was discovered in a genetic screen per-
formed in Drosophila [67,68]. The mutation was found to
lie in one of the ERK docking domains, the DRS. However,
the identification of the location of this mutation raised as
many questions as it answered. The DRS interacts with D
sites on MEK, substrates and deactivators alike, so why
would a mutation in the DRS necessarily lead to increased
ERK activity?
It is thought that the sevenmaker mutation has a detri-
mental effect on ERK activation, deactivation, and catalysis
individually. However, increased activity may arise from an
imbalance of this effect on different ERK-interacting pro-
teins. It is possible that deactivation of ERKby phosphatases
is more sensitive to disruption of the DRS than activation by
kinases or catalysis by ERK [68,69]. Thus, even if all binding
interactions involving the DRS are negatively impacted by
the sevenmaker mutation, if the disruption is more pro-
nounced in ERK phosphatases relative to ERK’s other bind-
ing partners, the ratio of active to inactive ERK increases.
Thus, in vivo effects of the sevenmaker mutation cannot be
reduced to binary interactions and must be considered
only in the context of a network.Mathematical Models for Enzyme Kinetics in Cells
Analysis of enzyme kinetics in cells, especially for highly
regulated enzymes with multiple substrates, requires anal-
ysis of enzyme networks. And just as Michaelis and Menten
based their work on measurements of reaction rates and
mathematical models of reaction progress, we need mathe-
matical models and experimental tools appropriate for net-
works. Are we there yet?
Most of the existing models of cell biochemistry assume
that enzymes, substrates, and complexes are perfectly
mixed. This might be true in vitro, but not in cells, where re-
action medium is highly crowded with macromolecules.
Recent work on ERK activation by MEK reveals that crowd-
ing has a strong effect on reaction kinetics [70]. When the
level of mixing is high, MEK phosphorylates ERK following
a distributive mechanism, whereby ERK is phosphorylated
on two different sites, in two distinct enzyme–substrate en-
counters, which can involve two different MEK molecules.
But when diffusion is slowed down by crowding, the mole-
cule that phosphorylated ERK for the first time binds to it
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the medium and carries out the second phosphorylation. In
this regime, a distributive mechanism appears as proces-
sive, whereby sequential modifications of the substrate
require just a single enzyme–substrate encounter.
This change in the apparent kinetics leads to a qualitative
change in the dynamics of the enzymatic cycle that controls
ERK phosphorylation. When ERK phosphorylation follows a
distributive mechanism, the cycle can have multiple steady
states [71], whereas the cycle in which ERK phosphorylation
is processive is always monostable [72]. This effect can be
readily captured by computational models that describe en-
sembles of individual enzymes and substrates, but not by
conventional chemical kinetics. Thus, some aspects of
enzyme kinetics in cells need models that differ from those
used by Michaelis and Menten.
A typical model of ERK dynamics provides information
about biochemical modification and subcellular locations of
multiple species. While only a small fraction of these species
can be measured by current experimental techniques, new
tools of cellular biochemistry, including quantitative prote-
omics, promise to expand the list of species and reactions
that canbemonitored in the samesample [58,73,74]. Further-
more, most of the current models of enzyme kinetics in cells
have been formulated based on data that neglect spatial
organization of cellular processes. However, rapid develop-
ment of live imaging techniques can provide data about
spatial distribution of network components and reaction
rates [75]. In parallel, advances in understanding the mecha-
nisms by which ERK interacts with substrates have led to the
developmentof live reportersof its enzymaticactivity [76–78].
Conclusions
Overall, when it comes to enzyme kinetics in cells, we are still
far from the experimental and conceptual standards estab-
lished by the 1913 paper. Given the complexity of these
processes and the fact that some of the key molecular
players have been discovered only recently, this should not
come as a surprise. At the same time, progress of experi-
mental techniques for monitoring different aspects of
enzyme kinetics in cells and our increasing ability to perturb
enzyme networks will inevitably lead to more advanced
physicochemical models [79]. Armed with these models,
we will be better equipped to predict how these networks
respond to genetic, environmental and pharmacological
perturbations.
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